Therapeutic Delivery – News and Features

A recent study by Tokyo’s Waseda University, reports a novel imaging technique that allows direct and highly sensitive tracking of drugs inside the body using gold nanoparticles.

A new weight loss treatment, Sirona, expands in the stomach to curb hunger. Phase 2 trials show promising results and the treatment could help transition patients off GLP-1 medications.

Tel Aviv University researchers used CRISPR to cut the SOX2 gene from head and neck cancer cells, eliminating 50% of tumors in mice. The study highlights CRISPR’s potential for cancer treatment.

Researchers have identified strains of one of the world's most dangerous pathogens that are five times more likely to acquire antifungal resistance.

Researchers have developed a stiff and strong hydrogel that self-heals when injured and behaved like human skin. The invention could have application in creating realistic artificial skin, as well as in drug delivery, wound healing and soft robotics.

A drug developed at The University of Texas Health Science Center at San Antonio (UT Health San Antonio) has been shown to extend survival for patients with glioblastoma, the most common primary brain tumor in adults.

A naturally occurring molecule resembles semaglutide in suppressing appetite and reducing body weight. Notably, animal testing also showed that it worked without some of the side effects of semaglutide.

A new technology from researchers at the California NanoSystems Institute at UCLA is aiming to turn the tables on tumors that migrate from the pancreas to the liver.

Researchers at Mass General Brigham found that a nasal spray delivering anti-CD3 (Foralumab) reduces neuroinflammation, limits central nervous system damage and improves behavioral outcomes in mice with traumatic brain injury.

A method developed by a research group at Tampere University seeks specific molecules that can target desired tissues through the bloodstream and penetrate tissues by passing through cells.